Article View: bionet.molbio.genearrays
Article #116Bio.com News & Updates
From: newsletter
Date: Thu, 07 Feb 2002 01:01
Date: Thu, 07 Feb 2002 01:01
337 lines
16744 bytes
16744 bytes
Bio.com News & Updates February 7, 2002 From Bio Online, Inc. The Life Sciences Portal(tm) www.bio.com | www.bioprotocol.com =========================================================================== CONTENTS: =========================================================================== 1. Science News: Immune Protein is Potential Drug Target 2. InFocus: Real-Time PCR: Emerging Applications 3. Career Fair: Genome 2002 Tri-Conference Career Fair Exhibition 4. Investment Research: Introducing Btech Investor 5. Market Research: Scientific and Medical Journals on the Web 6. Jobs of the Week: Research Associate and others =========================================================================== This newsletter is sponsored by: The BioWorld 2002 Genomics Review The BioWorld 2002 Genomics Review is a 300-page market report that provides comprehensive profiles of more than 200 public and private companies, including the major international players and small start-ups. The report also includes details on more than 1,000 genomics collaborations. Order this top-selling report today. Go to http://www.ahcpub.com/57441.html to order. =========================================================================== 1. SCIENCE NEWS =========================================================================== -Is Biologist Barry Commoner a Mutant? http://www.bio.com/Redirectors/LinkRedirect2_6.jhtml?link=1 Longtime radical activist and biologist Barry Commoner has just published a preposterous article in the February 2002 issue of Harpers that purports to call into question the "foundation of genetic engineering." Commoner claims to have uncovered a scandal at the heart of biology and biotechnology that the leading researchers and greedy corporations are keeping hidden from an unwitting public. -RNAi: More to RNA than Meets the Eye http://www.bio.com/Redirectors/LinkRedirect2_6.jhtml?link=2 Ask a leading molecular biologist to name the latest buzzword in biomedical research, and the answer may surprise you. It s not genomics, proteomics, or systems biology, but a term seldom heard in the popular pressRNAi. -Entrepreneurs and Hindsight Bias: It's Not Easy to Remember What We Remember http://www.bio.com/Redirectors/LinkRedirect2_6.jhtml?link=3 When you're reading about why a biotech business failed, don't you often think to yourself, "I could have turned that company around"? You do, don't you? And haven't you found yourself shaking your head in wonder at how people could have invested in those dot bombs? Haven't you said to yourself, "I could have seen that crash coming a mile away"? -Better Biotechnology Market Modeling: Balancing Simplicity and Complexity http://www.bio.com/Redirectors/LinkRedirect2_6.jhtml?link=4 Biotechnology executives frequently must make strategic marketing decisions based on limited information. Models that emphasize simplicity and adaptability yet capture the essence of a strategic issue can provide valuable assistance to decision-makers. -Immune Protein is Potential Drug Target http://www.bio.com/Redirectors/LinkRedirect2_6.jhtml?link=5 Researchers studying a protein implicated in the development of lupus and rheumatoid arthritis have discovered a unique domain crucial to the proteins function. The findings, reported in the February 8, 2002 issue of Cell, provide insight into an important immune-system protein and suggest that the protein may one day serve as a target for autoimmune therapy. -Miniaturization of the "Bionic Man" http://www.bio.com/Redirectors/LinkRedirect2_6.jhtml?link=6 Bionic limb replacements that look and work exactly like the real thing will likely remain a Hollywood fantasy, but fast advances in human-to-machine communication and miniaturization could bring the technology close within a decade. -Next Generation Biomaterials Heal Body http://www.bio.com/Redirectors/LinkRedirect2_6.jhtml?link=7 Writing in a review in the February 8, 2002 issue of the journal Science, Professors Larry Hench and Julia Polak of Imperial College, London, highlight the potential of 'third generation' biomaterials that activate specific cells and genes of the individual they are implanted into. -Direct View of Membrane Fusion Within Cells http://www.bio.com/Redirectors/LinkRedirect2_6.jhtml?link=8 Findings published in the February 8, 2002 issue of the journal Cell reveal a new mechanism of membrane fusion, a process that is essential for such life functions as nerve impulse transmission or hormone secretion in humans. To view all news, visit http://bio.com/news/research/ To view Industry news, visit http://bio.com/news/pr/ =========================================================================== 2. INFOCUS WEBCAST =========================================================================== Our next InFocus Webcast, "Real-Time PCR: Emerging Applications" is scheduled for Wednesday, February 13 at 1 pm Pacific Time. As cost-effective, flexible real-time PCR platforms become increasingly available, this powerful tool is moving beyond the domain of core laboratory facilities.Widespread access to real-time PCR is giving rise to a host of innovative applications, including gene expression and pathogen detection. This webcast will explore using this technique to tackle a variety of problems requiring the speed, accuracy and sensitivity that only real-time PCR can offer. Join us for a live discussion featuring these leaders in the field of real-time PCR: -Tony Godfrey, Ph.D. Assistant Professor of Surgery at the University of Pittsburgh Medical Center, Departments of Surgery and Human Genetics. -Norman Schaad, Ph.D. Research Plant Pathologist (bacteriologist) with the USDA/Agricultural Research Service, Foreign Disease-Weed Science Research Unit, Ft. Detrick, MD. -David Norwood, Ph.D. Assistant Chief of Systems, Development Branch, Diagnostic Systems Division, for the U.S. Army Medical Research Institute of Infectious Disease (USAMRIID). Sponsored by Cepheid (http://www.smartcycler.com/) *For more information, go to: http://www.bio.com/Redirectors/LinkRedirect2_6.jhtml?link=9 *For information on how to tune in to the live webcast, go to: http://www.bio.com/Redirectors/LinkRedirect01_23.jhtml?link=10 *To view past InFocus Webcast recordings and transcripts, go to: http://www.bio.com/newsfeatures/newsfeatures_fochives.jhtml *Bio.com's InFocus Webcast, "DNA Microarrays: Platforms and Applications," was broadcast Wednesday, December 12, 2001. To read the pdf transcript of this webcast, go to: http://www.bio.com/file_temp/platapps.pdf =========================================================================== 3. CAREER FAIR: GENOME 2002 TRI-CONFERENCE CAREER FAIR EXHIBITION =========================================================================== Bio.com and Cambridge Healthtech Institute Genome 2002 Tri-Conference Career Fair Exhibition http://www.bio.com/careercenter/careercenter_jobfair.jhtml -Date: February 23, 2002 -Location: Santa Clara Convention Center 5001 Great America Parkway Santa Clara, CA 95054 -Fee: Your Resume The Tri-Con Career Fair, organized by CHI and bio.com, provides job seekers with a forum to interact with hiring managers and human resource professionals from some of the worlds leading biotech and pharmaceutical organizations. This is a first rate tool for matching your skills with the right organization. Put yourself on the fast track with some of the hottest careers in the genomics industry; attend the Tri-Con Career Fair. In order to make your job searching experience more efficient and productive, please bring several copies of your resume with you. The career fair is free to all attendees. Click here to pre-register for the event: http://www.bio.com/careercenter/careercenter_jf_cambridgereg.jhtml =========================================================================== 4. INVESTMENT RESEARCH =========================================================================== Bio.com is pleased to welcome Btech Investor and SCO Financial Group as bio.com content partners. Btech Investor provides consulting on the biotechnology industry to the financial and biotechnology communities and publishes the Btech Investor Reports and Btech Investor News. For an example of Btech Investor's reports on the biotech industry, go to: http://www.bio.com/Redirectors/LinkRedirect01_03.jhtml?link=10 To purchase a subscription to Btech investor, or to browse and/or purchase individual reports, visit the bio.com store: http://www.bio.com/Redirectors/LinkRedirect2_6.jhtml?link=10 SCO Financial Group, a registered investment advisor focused on identifying emerging growth companies in the healthcare sectors, has made its investment research available, for free, to online investors at Bio.com. For an example, read their latest report on Connetics: http://www.bio.com/Redirectors/LinkRedirect2_6.jhtml?link=11 For more investment research from SCO Financial Group, go to: http://www.bio.com/Redirectors/LinkRedirect01_23.jhtml?link=11 =========================================================================== 5. MARKET RESEARCH =========================================================================== Bio.com offers the most comprehensive collection of market research available on the web. Check out these latest additions: -Marketing to Life Scientists: Keys to Success http://www.bio.com/Redirectors/LinkRedirect01_23.jhtml?link=12 This report is designed to help marketing professionals optimize their marketing mix in the academic, industrial and government segments of the life sciences market. -Scientific and Medical Journals on the Web http://www.bio.com/Redirectors/LinkRedirect01_23.jhtml?link=13 This major study examines the complex issues facing Scientific, Technical & Medical (STM) publishers as they confront the fast changing landscape of electronic publishing. -Functional Proteomics: Short-Cuts to Drug Discovery http://www.bio.com/Redirectors/LinkRedirect01_23.jhtml?link=14 Technical innovations that can dramatically reduce the time required to develop new therapeutics are driving the emergence of a new research field called functional proteomics, and companies engaging in this research could see huge growth in coming years. =========================================================================== 6. JOBS OF THE WEEK =========================================================================== Look at what's new on Bio.com Career Center this week: 1. Gilead Sciences: Manager, Clinical Data Programming http://career.bio.com/pages/jobsearch.cfm?object=5&job=775949&action=View 2. QLT Inc: Quality Control Analyst II http://career.bio.com/pages/jobsearch.cfm?object=5&job=776672&action=View 3. Pharmaceutical Product Development (PPD): Manager of Programming/Biostatistics http://career.bio.com/pages/jobsearch.cfm?object=5&job=776839&action=View 4. Perlegen Sciences: Research Associate http://career.bio.com/pages/jobsearch.cfm?object=5&job=775379&action=View 5. Great Smokies Diagnostics Laboratories: Technical Manager/Genomics & Molecular Biology http://career.bio.com/pages/jobsearch.cfm?object=5&job=776401&action=View 6. Biotechnology Company (Manufacturing): Applied Microbiologist http://career.bio.com/pages/jobsearch.cfm?object=5&job=776676&action=View 7. Research Company: Cancer Immunotherapy Scientist http://career.bio.com/pages/jobsearch.cfm?object=5&job=776711&action=View 8. Biotechnology Corporation: Director of Pharmacology http://career.bio.com/pages/jobsearch.cfm?object=5&job=776781&action=View Browse all jobs at http://career.bio.com/pages/featured.cfm?1 =========================================================================== This message is sent to <arrays@net.bio.net> per your request To unsubscribe, simply hit Reply from this email account <arrays@net.bio.net> and put the word 'unsubscribe' in the subject field. ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ Copyright © 2002, Bio Online. All rights reserved. ---
Technical Details
Message-ID:
<3541890.1013043758932.JavaMail.bio@proapp02.bio.com>Path:
arc1-ca.pugleaf.net!archiver1.google.com!news1.google.com!sn-xit-02!supernews.com!isdnet!newsfeed.online.be!ams.uu.net!lnewspeer00.lnd.ops.eu.uu.net!emea.uu.net!server1.netnews.ja.net!hgmp.mrc.ac.uk!owner-arraysShow Full Headers
Complete Article Headers
X-Google-Language: ENGLISH,ASCII
X-Google-Thread: f744d,f679a99266273590,start
X-Google-Attributes: gidf744d,public
X-Google-ArrivalTime: 2002-02-06 17:02:08 PST
Path: arc1-ca.pugleaf.net!archiver1.google.com!news1.google.com!sn-xit-02!supernews.com!isdnet!newsfeed.online.be!ams.uu.net!lnewspeer00.lnd.ops.eu.uu.net!emea.uu.net!server1.netnews.ja.net!hgmp.mrc.ac.uk!owner-arrays
From: newsletter@bio.com
Newsgroups: bionet.molbio.genearrays
Subject: Bio.com News & Updates
Date: 7 Feb 2002 01:01:59 -0000
Organization: BIOSCI/MRC Human Genome Mapping Project Resource Centre
Lines: 337
Sender: nobody@hgmp.mrc.ac.uk
Message-ID: <3541890.1013043758932.JavaMail.bio@proapp02.bio.com>
NNTP-Posting-Host: mercury.hgmp.mrc.ac.uk
Mime-Version: 1.0
Content-Type: text/plain; charset=646
Content-Transfer-Encoding: quoted-printable
X-Trace: niobium.hgmp.mrc.ac.uk 1013043720 24851 193.62.192.80 (7 Feb 2002 01:02:00 GMT)
X-Complaints-To: news@net.bio.net
NNTP-Posting-Date: Thu, 7 Feb 2002 01:02:00 +0000 (UTC)
X-Received: from localhost (localhost [127.0.0.1])
by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 8627D17B85
for <arrays@net.bio.net>; Thu, 7 Feb 2002 01:01:57 +0000 (GMT)
X-Received: from cns.bio.com (65-45-216-18.customer.algx.net [65.45.216.18])
by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 1797B17A8F
for <arrays@net.bio.net>; Thu, 7 Feb 2002 01:01:54 +0000 (GMT)
X-Received: from proapp02.bio.com ([199.165.130.217]) by cns.bio.com
(Post.Office MTA v3.5.2 release 221 ID# 0-0U10L2S100V35)
with ESMTP id com for <arrays@net.bio.net>;
Wed, 6 Feb 2002 16:00:23 -0500
X-To: arrays@net.bio.net